Product Description
Phalis M-Strol Tablets contain Megestrol Acetate IP 160 mg, a progestogen. Available from Pharmakon Lifesciences, Karnal, for PCD franchise and third-party manufacturing.
Indications
Loss of appetite and weight in cancer patients
Hormone-dependent breast and endometrial cancer
Dosage
As directed by the physician.
Side Effects
Nausea, breast tenderness, headache, spotting or mood changes may occur. Use only under the supervision of a gynaecologist.
Storage Instructions
Store in a cool, dry place below 30°C, protected from light and moisture.
Keep out of the reach of children.
Availability
Phalis M-Strol Tablets is available for PCD Pharma Franchise distribution and Third-Party Contract Manufacturing across India. Reach out to the manufacturer for pricing, MOQ and territory details.
Pharmaceutical Specifications
| Product Name | Phalis M-Strol Tablets |
| Dosage Form | Tablet |
| Composition | Megestrol Acetate IP 160 mg |
| Strength | N/A |
| Packing | 10x1x10 Alu-Alu (Mono Carton) |
| MRP | On Request |
| Prescription | Rx Required |
| Manufactured by | Pharmakon Lifesciences, Karnal |
| Delivery Time | 15–25 working days |
| Certifications | ISO 9001:2015 · WHO-GMP · Verified Company |
Company Information
Pharmakon Lifesciences
Karnal-based pharma company offering PCD franchise and third-party manufacturing in neuro, derma, gynae, ortho, dental and paediatric ranges. Operating since 2018.
